CytoSorbents Corporation (CTSO)

[Good Sport]

Avenir Corp Buys 132,235 Shares of Cytosorbents Co. (NASDAQ:CTSO)

"Avenir Corp increased its stake in Cytosorbents Co. (NASDAQ:CTSO - Get Rating) by 5.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,447,089 shares of the medical research company's stock after purchasing an additional 132,235 shares during the quarter. Cytosorbents makes up approximately 0.4% of Avenir Corp's portfolio, making the stock its 24th biggest holding. Avenir Corp owned 5.61% of Cytosorbents worth $3,793,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the stock. Millennium Management LLC bought a new stake in Cytosorbents during the 2nd quarter valued at $1,149,000. Skylands Capital LLC raised its holdings in Cytosorbents by 8.3% during the 4th quarter. Skylands Capital LLC now owns 2,542,091 shares of the medical research company's stock valued at $3,940,000 after acquiring an additional 195,057 shares during the period. Goldman Sachs Group Inc. raised its holdings in Cytosorbents by 129.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 298,877 shares of the medical research company's stock valued at $954,000 after acquiring an additional 168,712 shares during the period. Neuberger Berman Group LLC raised its holdings in Cytosorbents by 11.4% during the 3rd quarter. Neuberger Berman Group LLC now owns 1,479,570 shares of the medical research company's stock valued at $2,003,000 after acquiring an additional 151,300 shares during the period. Finally, Citadel Advisors LLC grew its position in shares of Cytosorbents by 461.4% during the 2nd quarter. Citadel Advisors LLC now owns 126,898 shares of the medical research company's stock valued at $278,000 after purchasing an additional 104,296 shares in the last quarter. Institutional investors own 34.04% of the company's stock."

https://www.marketbeat.com/instant-alerts/nasdaq-ctso-sec-filing-2023-06-12/